🏛️ Verified NIH Record • Updated 2026-08-07
A Study of Propranolol to Treat Kaposi Sarcoma (NCT05797662)
A Phase II Study of Propranolol for the Treatment of Kaposi Sarcoma in Children and Adults
🟡 Not Yet Recruiting Phase2 💊 Investigational Drug / Biologic Sponsor: AIDS Malignancy Consortium
🩺 Plain-English Summary (8th-Grade Level)
A clinical study of propranolol for the treatment of Kaposi Sarcoma in children and adults. This study will be an open-label single armed treatment trial that will test the effectiveness and the safety of treating Kaposi Sarcoma with propranolol.
Who can join: Review the eligibility criteria below.
Location: Fundación Huésped — Buenos Aires
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (6 Sites)
- Fundación Huésped — Buenos Aires,
- Instituto Nacional de Câncer José de Alencar — Rio de Janeiro,
- Complexo Hospitalar Universitário Professor Edgard Santos — Salvador,
- Instituto Nacional de Cancerologia — Mexico City,
- Uganda Cancer Institute — Kampala,
- University of Zimbabwe College of Health Sciences — Harare,
📞 Contact the Study Coordinator
Phone: (612) 301-2205
Email: smcallis@umn.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Kaposi Sarcoma
- Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma — Bethesda, Maryland
- Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis — Bethesda, Maryland
- Propranolol for the Treatment of Kaposi Sarcoma in Adults — St Louis, Missouri
- Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma — Bethesda, Maryland
- Natural History Study of Kaposi Sarcoma — Bethesda, Maryland
Explore by condition: All Kaposi Sarcoma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.